altCOPENHAGEN, Denmark – April 26, 2017 – Novozymes, the world’s largest producer of industrial enzymes, today announced its results for the first three months of 2017. Sales in Q1 grew by 3% organically and by 4% in DKK, mainly driven by Food & Beverages and Bioenergy. EBIT grew by 6%, and the EBIT margin improved by 0.7 percentage point to 27.0%. Adjusting for the extraordinary costs related to the lay-offs in January, the EBIT margin would have been around 29%. The outlook for 2017 is maintained.

We have made solid progress on our strategic priorities in the first quarter of 2017. As part of the organizational changes, resources are being focused on high-growth opportunities and growth markets, and we have continued our significant investments in R&D and technology leadership. We have also made good progress in our innovation pipeline and launched two new solutions in Bioenergy and BioAg. Furthermore, in March we embarked on a new strategic collaboration with Boehringer Ingelheim in probiotics for poultry hatcheries.

Peder Holk Nielsen, President and CEO of Novozymes, comments:

“It’s been a good start to the year. The majority of our markets have developed well, and profitability was high. I’m pleased to see that we’re making progress on our strategic priorities, exemplified by the recent collaboration with Boehringer Ingelheim in probiotics for poultry hatcheries. Finally, our pipeline of new innovation is advancing. All in all: positive developments in Q1.”

Novozymes’ executive leadership team will present the results at a conference call today at 12:00 pm CET: https://novozymes.eventcdn.net/2017q1/

The entire earnings report can be downloaded at novozymes.com.


About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet’s resources and helping build better lives. As the world’s largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

NASDAQ OMX: NZYM-B • 6,500 employees • DKK 14 billion turnover • 30+ industries • 700+ products


Ajouter un Commentaire


Code de sécurité
Rafraîchir

Vitrines Sociétés

Voir toutes les vitrines